Remote Monitoring and Optimization of Oxygen Therapy for Premature Infants with Bronchopulmonary Dysplasia in the Czech Republic

What this Trial Is About

This research aims to develop and test a national approach for remotely monitoring and optimizing oxygen therapy in premature infants diagnosed with bronchopulmonary dysplasia in the Czech Republic. The goal is to reduce health risks and negative impacts on the childs development and family by improving care for preterm newborns. The project is a prospective, multicenter, interventional pilot involving four perinatology centers. Premature infants with bronchopulmonary dysplasia who require low-flow nasal cannulas for oxygen will be included. Their oxygen therapy will be managed remotely using specialized pulse oximeters that continuously monitor oxygen saturation. Treatment adjustments will follow established protocols to safely and earlier reduce oxygen therapy, including tests involving oxygen flow reduction and overnight monitoring. The project is supported by the European Social Fund and the Czech Republic government. Participants will be closely monitored from enrollment until four weeks after stopping home oxygen therapy. Researchers will track oxygen saturation levels continuously and assess the duration of oxygen therapy and the number of therapy failures before termination. The study includes remote monitoring, data collection, and adherence to protocols to optimize care and ensure safety throughout the process.

Controlled Remote Monitoring and Optimization of Oxygen Therapy in Preterm Infants